TAP Pipeline - Sept04, Oct05, Oct06 Row Status Synonyms Status - Lestaurtinib - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2008-07-19 12:33:45 Lactams TAP Pharmaceuticals Drugs TAP Pharmaceutical Products Uterine fibroid Lestaurtinib Prostate cancer Asoprisnil Progesterone Endocrine system Medicine Chemistry		TAP Pipeline - Sept04, Oct05, Oct06 Row Status Synonyms Status Add to Reading List Source URL: www.bizcharts.com Download Document from Source Website File Size: 43,67 KB Share Document on Facebook

	AMBIT BIOSCIENCES AND ASTELLAS ENTER STRATEGIC PARTNERSHIP TO RESEARCH, DEVELOP AND COMMERCIALIZE FLT3 KINASE INHIBITORS IN MULTIPLE INDICATIONS Ambit to Receive a $40 Million Upfront Cash Payment; Up to $350 Million DocID: M2Hw - View Document
	e:aple ChartsbTAP06Oct.cht DocID: nTd5 - View Document
	TAP Pipeline - Sept04, Oct05, Oct06 Row Status Synonyms Status DocID: nQiu - View Document
	AMBIT BIOSCIENCES INITIATES FIRST PHASE 2 CLINICAL TRIAL OF AC220 IN ACUTE MYELOID LEUKEMIA Potential to Support U.S. Regulatory Filing DocID: eryD - View Document
	Microsoft Word[removed]Partnership with Ambit.doc DocID: epx9 - View Document